Understanding Usher Syndrome and Vision Testing

Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in MYO7A

Recruiting Observational Study
Usher Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 – 75
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts · Other
Who this trial is looking for

This trial is looking for people with Usher Syndrome type 1 who are at least 3 years old. Participants will help researchers learn more about vision loss and test new ways to measure vision using virtual reality.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 3 years old.
  • I have been diagnosed with Usher Syndrome type 1 in both eyes.
  • I have a social security system affiliation.
  • I can understand spoken and signed French.
  • I have a cochlear implant.
  • I am between 18 and 75 years old.

You may not be able to join if

  • I cannot participate in all study visits.
  • I am expected to enter another treatment trial during this study.
  • I have serious eye problems other than retinitis pigmentosa.
  • I have participated in a previous gene replacement trial.
  • I am pregnant, delivering, or breastfeeding.
  • I am under judicial or administrative custody.
  • I am under legal protection measures or cannot give consent.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Inherited retinal diseases (IRDs) are a group of degenerative disorders that cause progressive vision loss. Retinitis pigmentosa (RP) is the most common form, with a global prevalence of approximately 1 in 4,500. About 20-30% of these cases are syndromic, most notably Usher syndrome (USH), which combines hearing loss with visual impairment. Usher syndrome type 1 (USH1), the most severe form, prese…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Be at least 3 years old; * Have a clinical diagnosis of USH1 in both eyes, meaning subjects with congenital profound deafness, vestibular dysfunction, and rod dystrophy, carrying biallelic class 4 or 5 variants in the MYO7A gene; * Be affiliated with or beneficiary of a social…
Contacts

Isabelle AUDO, Pr

+330140021430

isabelle.audo@inserm.fr

CONTACT

Thilissa DIB

+33014021455

tdib@15-20.fr

CONTACT